Related Experiment Video
Updated: Jun 29, 2025
Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model
Published on: September 20, 2020
Recent advances in mesenchymal stem cell therapy for myocardial infarction
Yu-Chuan He1, Guo-Dong Yuan2, Nan Li3
1Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.
Insights
Mesenchymal stem cell (MSC) therapy shows promise for treating myocardial infarction, offering an effective and safe approach. Further research is needed to standardize MSC transplantation protocols for widespread clinical use.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Myocardial infarction (MI) is ischemic necrosis of heart muscle due to coronary artery occlusion, a major health threat.
- Current treatments to reduce myocardial oxygen demand have limited success.
- Mesenchymal stem cells (MSCs) show potential for MI treatment.
Purpose of the Study:
- To review the effectiveness and safety of mesenchymal stem cell implantation for myocardial infarction.
- To identify challenges and areas for standardization in MSC transplantation protocols for cardiac repair.
Main Methods:
- Review of accumulated clinical evidence on mesenchymal stem cell therapy for myocardial infarction.
- Analysis of existing data regarding MSC transplantation protocols, dosage, and administration routes.
Main Results:
- Clinical evidence indicates that mesenchymal stem cell implantation is both effective and safe for treating myocardial infarction.
- Variability and controversy exist regarding standardized MSC transplantation protocols, optimal dosage, and administration routes.
Conclusions:
- Mesenchymal stem cell therapy is a promising treatment for myocardial infarction.
- Standardizing MSC transplantation protocols is crucial for integrating this therapy into mainstream cardiac treatment.
Abstract:
Myocardial infarction refers to the ischemic necrosis of myocardium, characterized by a sharp reduction or interruption of blood flow in the coronary arteries due to the coronary artery occlusion, resulting in severe and prolonged ischemia in the corresponding myocardium and ultimately leading to ischemic necrosis of the myocardium. Given its high risk, it is considered as one of the most serious health threats today. In current clinical practice, multiple approaches have been explored to diminish myocardial oxygen consumption and alleviate symptoms, but notable success remains elusive. Accumulated clinical evidence has showed that the implantation of mesenchymal stem cell for treating myocardial infarction is both effective and safe. Nevertheless, there persists controversy and variability regarding the standardizing MSC transplantation protocols, optimizing dosage, and determining the most effective routes of administration. Addressing these remaining issues will pave the way of integration of MSCs as a feasible mainstream cardiac treatment.
Related Concept Videos
01:19Mesenchymal Stem Cells
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...